The Recall Desk

FDA (Drugs) recall action 84526

Motto International Corp recalled 4 products on 2020-01-22

The FDA (Drugs) publishes a recall like this one as 4 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 4 pages.

Products
4
Announced
2020-01-22
Critical
4
Units
21

Why these products were recalled

Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

States named across these recalls

1–4 of 4

  • CriticalFDA (Drugs)··2020-01-22

    FDA Recalls Rhino 7 Platinum 30000 Capsules for Unapproved Tadafila Content

    Motto International Corp is recalling Rhino 7 Platinum 30000 Capsules because FDA analysis found the product contains tadalafil, an unapproved active ingredient.

    Product
    Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX
    Category
    Distribution
    1 state
  • CriticalFDA (Drugs)··2020-01-22

    FDA Recalls Panther Platinum 30000 Capsules for Unapproved Tadalfil Content

    Motto International Corp is recalling Panther Platinum 30000 Capsules because FDA analysis found the product contains tadalfil and was marketed without an approved NDA or ANDA.

    Product
    Panther Platinum 30000 Capsules, in green, black background with white, red text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX
    Category
    Distribution
    1 state
  • CriticalFDA (Drugs)··2020-01-22

    FDA Recalls Unapproved Bull Platinum 30000 Capsules Containing Tadalafil

    Motto International Corp is recalling Bull Platinum 30000 Capsules because FDA analysis found the product contains tadalafil, a prescription drug, and it was marketed without an approved NDA or ANDA.

    Product
    Bull Platinum 30000 Capsules, 1000 mg, in orange, white, yellow background with silver text, packaged in 2, 4 and 10 count blister cards, Motto International, Dallas, TX
    Category
    Distribution
    1 state
  • CriticalFDA (Drugs)··2020-01-22

    FDA Recalls Unapproved Stallion Platinum 30000 Capsules Containing Tadalafil

    Motto International Corp is recalling Stallion Platinum 30000 Capsules because FDA analysis found the unapproved product contains tadalafil.

    Product
    Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper packaging, packaged in 2, 4, 10 count blister cards, Motto International, Dallas, TX
    Category
    Distribution
    1 state